The lack of a main effect of immune-related conditions in our study does not preclude a role for these conditions in the aetiology of glioma insofar as a prior diagnosis of an immune-related condition significantly modified the associations of glioma risk with IL-15 and IL-16. This evidence concerns the gene IL15 and central nervous system cancer.